Treatment of patients with advanced cancer using tumor infiltrating lymphocytes transduced with the gene of resistance to neomycin.
Favrot
M C
MC
Philip
T
T
D002985:Clinical Protocols; D003131:Combined Modality Therapy; D004351:Drug Resistance / Q000235:genetics; D005822:Genetic Vectors; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use; D016246:Lymphocytes, Tumor-Infiltrating / Q000378:metabolism / Q000637:transplantation*; D008979:Moloney murine leukemia virus / Q000235:genetics; D009355:Neomycin / Q000494:pharmacology*; D009369:Neoplasms / Q000628:therapy*; D014161:Transduction, Genetic
D007376:Interleukin-2; D009355:Neomycin